Literature DB >> 30408153

MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma.

Laura S Hiemcke-Jiwa1, Roos J Leguit1, Tom J Snijders2, Jacoline E C Bromberg3, Stefan Nierkens4, N Mehdi Jiwa1, Monique C Minnema5, Manon M H Huibers1.   

Abstract

Entities:  

Keywords:  zzm321990MYD88zzm321990; cell-free DNA; droplet digital PCR; liquid biopsy; primary central nervous system lymphoma

Mesh：

Substances：

Year:  2018        PMID： 30408153     DOI： 10.1111/bjh.15674

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

Review 1.  Liquid biopsy in lymphoma: Molecular methods and clinical applications.

Authors:  Melita Cirillo; Alexander F M Craig; Sven Borchmann; David M Kurtz
Journal:  Cancer Treat Rev       Date:  2020-09-22       Impact factor: 12.111

Review 2.  Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review.

Authors:  Susana Olmedillas-López; Rocío Olivera-Salazar; Mariano García-Arranz; Damián García-Olmo
Journal:  Mol Diagn Ther       Date:  2021-11-13       Impact factor: 4.074

Review 3.  ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.

Authors:  Laura Escudero; Francisco Martínez-Ricarte; Joan Seoane
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

4.  Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas.

Authors:  Sabela Bobillo; Marta Crespo; Laura Escudero; Regina Mayor; Priyanka Raheja; Cecilia Carpio; Carlota Rubio-Perez; Bárbara Tazón-Vega; Carlos Palacio; Júlia Carabia; Isabel Jiménez; Juan C Nieto; Julia Montoro; Francisco Martínez-Ricarte; Josep Castellvi; Marc Simó; Lluis Puigdefàbregas; Pau Abrisqueta; Francesc Bosch; Joan Seoane
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

5.  Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.

Authors:  Adam J Olszewski; Anna D Chorzalska; Max Petersen; Thomas A Ollila; Adam Zayac; Habibe Kurt; Diana O Treaba; John L Reagan; Andrew Hsu; Pamela C Egan; James Butera; Rabin Niroula; John Vatkevich; Jordan Robison; Ilyas Sahin; Allison P Jacob; Chelsea D Mullins; Patrycja M Dubielecka
Journal:  Blood Adv       Date:  2021-12-28

6.  Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses.

Authors:  Chisako Iriyama; Kenichiro Murate; Sachiko Iba; Akinao Okamoto; Hideyuki Yamamoto; Ayana Kanbara; Akane Sato; Emiko Iwata; Ryuta Yamada; Masataka Okamoto; Hirohisa Watanabe; Tatsuro Mutoh; Akihiro Tomita
Journal:  Ann Hematol       Date:  2021-10-02       Impact factor: 3.673

Review 7.  The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies.

Authors:  Rafael Colmenares; Noemí Álvarez; Santiago Barrio; Joaquín Martínez-López; Rosa Ayala
Journal:  Cancers (Basel)       Date:  2022-03-03       Impact factor: 6.639

Review 8.  Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.

Authors:  Eliza M Lauer; Jurik Mutter; Florian Scherer
Journal:  Leukemia       Date:  2022-06-14       Impact factor: 12.883

9.  Effectiveness of digital PCR for MYD88L265P detection in vitreous fluid for primary central nervous system lymphoma diagnosis.

Authors:  Kun Chen; Yanchun Ma; Tianling Ding; Xinju Zhang; Bobin Chen; Ming Guan
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.